Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bartens

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 11, 1999
[AIDS--the forgotten pandemic?]W Bartens
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality?C Wanner, W Bartens
The Clinical Investigator|August 1, 1994
Lipoprotein(a): new insights into an atherogenic lipoproteinW Bartens, C Wanner
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996
[Combination antihypertensive therapy in patients with an increased risk profile]W Bartens, M Nauck, C Wanner
Kidney International. Supplement|December 1, 1995
Clinical utility of antilipidemic therapies in chronic renal allograft failureC Wanner, W Bartens, J Galle
Metabolism: Clinical and Experimental|July 1, 1997
Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)--but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)]--in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptorW Bartens, A Krämer-Guth, C Wanner
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patientsW Bartens, M Nauck, P Schollmeyer, et al.
European Journal of Clinical Investigation|September 1, 1995
Lipoprotein (a) in patients with hyperlipidaemiaW Bartens, D J Rader, G Talley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patientsC Wanner, W Bartens, G Walz, et al.
Atherosclerosis|August 1, 1994
Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemiaW Bartens, D J Rader, G Talley, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|September 11, 1999
[AIDS--the forgotten pandemic?]W Bartens
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality?C Wanner, W Bartens
The Clinical Investigator|August 1, 1994
Lipoprotein(a): new insights into an atherogenic lipoproteinW Bartens, C Wanner
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996
[Combination antihypertensive therapy in patients with an increased risk profile]W Bartens, M Nauck, C Wanner
Kidney International. Supplement|December 1, 1995
Clinical utility of antilipidemic therapies in chronic renal allograft failureC Wanner, W Bartens, J Galle
Metabolism: Clinical and Experimental|July 1, 1997
Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)--but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)]--in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptorW Bartens, A Krämer-Guth, C Wanner
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patientsW Bartens, M Nauck, P Schollmeyer, et al.
European Journal of Clinical Investigation|September 1, 1995
Lipoprotein (a) in patients with hyperlipidaemiaW Bartens, D J Rader, G Talley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patientsC Wanner, W Bartens, G Walz, et al.
Atherosclerosis|August 1, 1994
Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemiaW Bartens, D J Rader, G Talley, et al.
Pageof 2